Medicare Enrolled
Dr. Hermes Velasquez, MD
Pulmonary Disease · Vero Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Velasquez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Velasquez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Velasquez
Dr. Hermes Velasquez is a pulmonary disease specialist in Vero Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Velasquez performed 2,548 Medicare services across 1,939 unique beneficiaries.
Between the years covered by Open Payments, Dr. Velasquez received a total of $9,759 from 32 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Velasquez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in FL
$9,759 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 88994 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗2,548
Medicare services
Top 23% in FL for pulmonary disease
1,939
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~134 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
901 | $76 | $206 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
285 | $98 | $246 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
186 | $50 | $170 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
113 | $7 | $22 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
113 | $181 | $649 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
112 | $9 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
112 | $142 | $1,041 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
111 | $8 | $542 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
107 | $102 | $304 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
98 | $64 | $170 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
59 | $83 | $1,404 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
51 | $94 | $1,472 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
47 | $41 | $583 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
47 | $18 | $80 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
39 | $91 | $2,689 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
32 | $36 | $341 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
27 | $6 | $82 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
23 | $34 | $117 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
21 | $11 | $117 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
15 | $105 | $1,616 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $112 | $240 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
12 | $74 | $3,047 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
12 | $54 | $832 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
12 | $121 | $1,028 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,759
Total received (2018-2024)
Avg $1,394/year across 7 years
Top 21% in FL for pulmonary disease
32
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,466 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$293 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,262
2023
$1,861
2022
$1,519
2021
$1,418
2020
$582
2019
$1,659
2018
$457
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Pulmonx Corporation
$1,608
Veran Medical Technologies, Inc.
$1,408
BOSTON SCIENTIFIC CORPORATION
$862
GlaxoSmithKline, LLC.
$792
AstraZeneca Pharmaceuticals LP
$780
Actelion Pharmaceuticals US, Inc.
$736
Ethicon Inc.
$731
ABIOMED
$504
United Therapeutics Corporation
$500
Bayer Healthcare Pharmaceuticals Inc.
$304
HARMONY BIOSCIENCES LLC
$225
Mylan Specialty L.P.
$215
Gilead Sciences, Inc.
$202
Regeneron Healthcare Solutions, Inc.
$141
Baxter Healthcare
$92
Auris Health, Inc.
$85
Inspire Medical Systems, Inc.
$72
Covidien LP
$71
Genentech USA, Inc.
$53
Amgen Inc.
$52
Philips Electronics North America Corporation
$50
Bayer HealthCare Pharmaceuticals Inc.
$49
GENZYME CORPORATION
$37
Merck Sharp & Dohme LLC
$27
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$26
Grifols USA, LLC
$25
Abbott Laboratories
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
PFIZER INC.
$18
Insmed, Inc.
$17
ICU Medical Inc
$17
Ambu Inc.
$12
Top 3 companies account for 39.7% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · AREXVY · AVEIR · Adempas · Arikayce · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUPIXENT · ELIQUIS · Esbriet · FASENRA · GENERAL THERAPIES · GLASSIA · General - Therapies · INSPIRE · Impella · Letairis · LifeVest · Monarch · Monarch Platform · NUCALA · OPSUMIT MACITENTAN · Prolastin-C · Spin · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Tracheostomy · Trilogy 100 · UPTRAVI · WAKIX · Wakix · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $383 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
14
Per 100K population
8.5
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Velasquez is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Velasquez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Velasquez performed 901 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Velasquez receive payments from pharmaceutical companies?
Yes. Dr. Velasquez received a total of $9,759 from 32 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Velasquez's costs compare to other pulmonary diseases in Vero Beach?
Dr. Velasquez's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Velasquez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Vero Beach
Browse pulmonary diseases in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
By company
Veran Medical Technologies, Inc. Payments to Doctors
See all physicians who received payments from Veran Medical Technologies, Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology